Zoetis enters the second half of 2026 with a rare alignment of signals pointing in the same direction: the stock is falling, short sellers are building, and analysts are cutting targets with unusual consistency.
The most striking development this week is the breadth of analyst capitulation. Target prices have moved in one direction only. Barclays slashed its target from $136 to $85 yesterday while keeping an Equal-Weight rating. TD Cowen, holding a Buy, dropped its target from $150 to $104. Stifel, already at Hold, cut again — from $95 to $85, its second reduction in five weeks. The consensus mean now sits at $118, against a current price of $71.86, a gap that sounds bullish but largely reflects the lag between street targets and a stock that has fallen roughly 55% from its highs. JPMorgan remains the most constructive major voice at Overweight but cut its target to $130 in May. The overall direction of travel is clear: firms are still anchored above current levels, but they are moving down fast.
The bear thesis centres on what happened at the May 7 earnings print. The stock dropped 25.5% in a single session and extended those losses to 32% over the following five days — the kind of reaction that resets investor expectations and invites fresh short positioning. Short interest reflects exactly that. Bears have added roughly 28% to their position over the past month, pushing the short interest to 3.9% of free float. That level is not extreme in absolute terms, but the rate of change is notable: shares short jumped nearly 18% in the past week alone, the most aggressive weekly buildup in the 30-day window. The ORTEX short score has ticked up steadily, reaching 36.2 from 34.0 two weeks ago.
The borrow market offers no friction to that build. Availability is exceptionally loose — shares available to lend dwarf current short demand by a factor of roughly 29 to 1. Cost to borrow has eased to 0.46%, down from above 0.75% earlier in the week and off roughly 19% over the past month. There is no squeeze pressure here. Shorts face negligible carrying costs and ample supply, which removes one of the usual circuit-breakers on short-side momentum. Options positioning adds a small amount of colour: the put/call ratio at 0.48 is nearly in line with its 20-day average of 0.47 and far below the 52-week high of 1.29, so options traders have not rushed to hedge aggressively despite the drawdown.
Insider behaviour provides the most interesting counterpoint. Three directors stepped in to buy stock in mid-May, in the week after the earnings collapse. The chairman purchased 3,000 shares at $77.76, while independent director Frank Damelio bought 6,650 shares at $75.39. Together with a smaller purchase from director Paul Bisaro, the cluster totalled roughly $886,000 in open-market buys. That the stock has since drifted further to $71.86 means the buyers are currently underwater, which either validates the bears' conviction or sets up a more interesting story if the fundamental picture stabilises before August earnings.
The next fixed point is the Q1 results scheduled for August 5. The magnitude of the May reaction — the largest single-day move in the recent history shown here — means that print will carry more weight than usual. What to watch between now and then is whether the weekly pace of short-interest accumulation persists, and whether any analyst moves to cut their rating outright rather than simply trimming targets, which would mark a qualitative shift in Street conviction that the current numbers have not yet delivered.
See the live data behind this article on ORTEX.
Open ZTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
